Consultant Cover Letter
CEO, Capellon Pharmaceuticals
This memo serves as an introduction to my consulting services and a briefing of the work I have just completed for Capellon. I met with Alexi Parsons two weeks earlier to outline a plan for my consultation and to set this day as the target for completion of my research. Below, I describe my perspective of the challenges Capellon faces, my research findings, and my recommendations to you and the board of directors.
Challenges. Productivity and morale have decreased company-wide. Resources have been heavily allocated to the marketing department, but year-over-year sales fell markedly.
Staff resisted required changes in policies and interactions have...
Consequently, turnover had reached unacceptable levels that threaten to mare the company's reputation in the industry. The marketing manager does not have leeway to function effectively and is chronically micromanaged by superiors who do not understand the operations of the business unit. Upper level managerial missteps have been so acute as to assume installing surveillance cameras in the marketing department would actually contribute something of value. The absence of quality and risk management programs creates a barrier to systematic improvement and fails to prepare the company for the large burden of risk and crisis management that pharmaceuticals companies must recognize.
Recommendations. Decentralization…
Corporate Social Responsibility in Indian Pharmaceutical Industry An Exploratory Study Outlook of CSR in India History of CSR in India Philanthropy in Indian Society Modern Form of CSR in Indian Society Profile of Indian Pharmaceutical Industry Rationale for Selection CSR Activities by Indian Pharmaceutical Companies Major Influences Over CSR Activities Scope of CSR Activities Comparison of Indian & Western Pharmaceutical Companies This research paper is concerned with the recent practices of Indian pharmaceutical companies in the field of corporate social responsibility. For
Integration of Anti-Counterfeit Technology in the Pharmaceutical Supply Chain Organisational Background Rationale for Strategic Action Plan Strategic Aims and Objectives Levers and Obstacles Analysis of Internal Capabilities -- Strengths and Weaknesses Trends and External Forces -- Opportunities and Threats Stakeholder Influence Strategic Action Plan Key Actions, Actors, and Responsibilities Timeline and Milestones Cost Analysis Risk and Barriers Mechanisms to Track Progress Organizational Background The organization, Cure Pharmaceutical (Cure), operates in the pharmaceutical industry's drug delivery technology segment. Cure is considered a small pharmaceutical company with
These claims are virtually all based on the concept that corporations - particularly multinationals -- should be held accountable for their actions within their sphere of operations. "Corporations, for their part, have responded in numerous ways, from denying any duties in the area of human rights to accepting voluntary codes that could constrain their behavior" (Ratner, 2001, p. 436). In fact, this very point is echoed throughout the literature; for
Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense
This is a very positive feature of the university that sets it apart from other facilities. I see the path to choosing my major as an experience that will build my self-esteem and allows me to understand a lot more about myself. Of all the personal development options available at the university I consider self understanding and awareness the most important. It allows the individual to find their best fit
Marketing Plan for Ford Motors Company The logic is really very simple -- when a model is supposed to be for women, it has to be designed by women. It is clear that cars are now being purchased in USA for both men and women, and many times, women have their own cars. This fact had been realized as early as 1956 when there was a model called Dodge La Femme for